Gilead Sciences · 2 days ago
Intern - Research - Project Management
Gilead Sciences is dedicated to creating a healthier world by tackling significant diseases. The intern will contribute to high-impact projects, gaining real-world experience while participating in professional development and community engagement activities.
BiopharmaBiotechnologyHealth CareManufacturingPharmaceutical
Responsibilities
Working knowledge of AI tools and platforms, including Gilead-Copilot Suite
Capacity to identify trends, bottlenecks, and under-supported areas using AI-driven analysis
Ability to work across functions such as Clinical Development, Regulatory, DMPK, NSP and MedChem
Capacity to identify trends, bottlenecks, and under-supported areas using AI-driven analysis
Showcase your work with a final presentation (PPT) near the conclusion of your internship
Qualification
Required
Must be at least 18 years old
Must have a minimum GPA of 2.8
Authorized to work in the United States without Sponsorship now or in the future or CPT/OPT through your University
Must be currently enrolled as a full-time student in a Bachelor's/Masters/MBA/PhD program at an accredited US based university or college
Must be a Rising Sophomore, Junior, or Senior in undergrad or a Graduate or Doctoral Student
Must be enrolled full-time in the Fall Semester at an accredited university/college after the completion of the internship
Must be able to complete a 10-12 consecutive week internship between May and August
Must be able to relocate if necessary and work at the designated site for the duration of the internship
Preferred
Preferred Degree qualification: Undergrad
Proficiency with MS Office Suite
Ability to identify issues and seek solutions
Ability to work both independently and collaboratively
Demonstrated commitment to inclusion and diversity in the workplace
Efficient, organized, and able to handle short timelines in a fast-paced environment
Benefits
Paid company holidays
Sick time
Housing stipends for eligible employees
Company
Gilead Sciences
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.
Funding
Current Stage
Public CompanyTotal Funding
$4.41BKey Investors
Abingworth
2024-11-13Post Ipo Debt· $3.5M
2024-02-29Post Ipo Equity· $210M
2023-09-07Post Ipo Debt· $2B
Leadership Team
Recent News
2026-01-09
2026-01-08
2026-01-07
Company data provided by crunchbase